National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting, 73895 [2014-29160]
Download as PDF
<![CDATA[
Federal Register / Vol. 79, No. 239 / Friday, December 12, 2014 / Notices
Cancer Control, National Institutes of Health,
HHS)
DEPARTMENT OF HOMELAND
SECURITY
Dated: December 8, 2014.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[Docket No. DHS–2014–0007]
[FR Doc. 2014–29161 Filed 12–11–14; 8:45 am]
AGENCY:
Critical Infrastructure Private Sector
Clearance Program Request (CI PSCP)
National Protection and
Programs Directorate, DHS.
ACTION: 30-day notice and request for
comments; new information collection
request: 1670–0013.
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
The Department of Homeland
Security (DHS), National Protection and
Programs Directorate (NPPD), Office of
Infrastructure Protection (IP) will
submit the following Information
Collection Request to the Office of
Management and Budget (OMB) for
review and clearance in accordance
with the Paperwork Reduction Act of
1995 (Pub. L. 104–13, 44 U.S.C. Chapter
35). DHS previously published this
Information Collection Request (ICR) in
the Federal Register on September 24,
2014, for a 60-day public comment
period. DHS received no comments. The
purpose of this notice is to allow an
additional 30 days for public comments.
DATES: Comments are encouraged and
will be accepted until January 12, 2015.
This process is conducted in accordance
with 5 CFR 1320.10.
ADDRESSES: Written comments and
questions about this ICR should be
forwarded to DHS/NPPD/IP/Attn:
Cheryl Fenoli, 245 Murray Lane SW.,
Mail Stop 0607, Arlington, VA 20598–
0609. Email requests should go to
Cheryl Fenoli, Cheryl.Fenoli@
hq.dhs.gov. Written comments should
reach the contact person listed no later
than January 12, 2015. Comments must
be identified by ‘‘DHS–2014–0007’’and
may be submitted by one of the
following methods:
• Federal eRulemaking Portal: https://
www.regulations.gov.
• Email: Include the docket number
in the subject line of the message.
Instructions: All submissions received
must include the words ‘‘Department of
Homeland Security’’ and the docket
number for this action. Comments
received will be posted without
alteration at https://www.regulations.gov,
including any personal information
provided.
SUMMARY:
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
mstockstill on DSK4VPTVN1PROD with NOTICES
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; NIAID SBIR Phase II
Clinical Trial Implementation Cooperative
Agreement (U44).
Date: January 6, 2015.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: 5601 Fishers Lane, Room 3G62,
Rockville, MD 20852, (Telephone Conference
Call).
Contact Person: Travis J. Taylor, Ph.D.,
Scientific Review Program DEA/NIAID/NIH/
DHHS, 5601 Fishers Lane, Rockville, MD
20852, 240–669–5082, Travis.Taylor@
nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: December 8, 2014.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–29160 Filed 12–11–14; 8:45 am]
BILLING CODE 4140–01–P
VerDate Sep<11>2014
16:57 Dec 11, 2014
Jkt 235001
The CI
PSCP sponsors clearances for privatesector partners who are responsible for
critical infrastructure protection in
accordance with Executive Order 13549.
The PSCP requires individuals to
complete a clearance request form that
initiates the clearance process. Sector
Specific Agencies (SSAs), NPPD/IP
SUPPLEMENTARY INFORMATION:
PO 00000
Frm 00017
Fmt 4703
Sfmt 4703
73895
Protective Security Advisors, Sector
Liaisons, the National Infrastructure
Coordinating Center, and other federal
officials designated by NPPD/IP are
authorized to submit nominations to the
central PSCP point of contact, the PSCP
Administrator. The clearance request
form is signed by both the federal
official who nominated the applicant
and by the Assistant Secretary for IP
prior to initiating the clearance process.
Upon approval by the Assistant
Secretary for IP, IP Security Office will
contact the nominee to obtain the social
security number, date and place of birth,
and will then enter this data into eQIP—Office of Personnel Management’s
secure portal for investigation
processing. Once the data is entered in
e-QIP, the applicant can complete the
online security questionnaire. An
alternate mailing address is an optional
field on the form and may be provided
if the nominee chooses to have
correspondences sent to a mailing
address other than the company mailing
address. The IP Security Office
maintains all applicants’ information in
the Master Roster, which contains all
the information found on the clearance
request form in addition to their
clearance information (date granted,
level of clearance, date non-disclosure
agreements signed, and type/date of
investigation). The Administrator of the
Master Roster maintains the information
so as to track clearance processing and
investigation information and to have
the most current contact information for
the participants from each sector.
OMB is particularly interested in
comments that:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected; and
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses.
Analysis
Agency: Department of Homeland
Security, National Protection and
E:\FR\FM\12DEN1.SGM
12DEN1
]]>Agencies
[Federal Register Volume 79, Number 239 (Friday, December 12, 2014)]
[Notices]
[Page 73895]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-29160]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel; NIAID SBIR Phase II Clinical Trial
Implementation Cooperative Agreement (U44).
Date: January 6, 2015.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: 5601 Fishers Lane, Room 3G62, Rockville, MD 20852,
(Telephone Conference Call).
Contact Person: Travis J. Taylor, Ph.D., Scientific Review
Program DEA/NIAID/NIH/DHHS, 5601 Fishers Lane, Rockville, MD 20852,
240-669-5082, Travis.Taylor@nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS)
Dated: December 8, 2014.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2014-29160 Filed 12-11-14; 8:45 am]
BILLING CODE 4140-01-P
